In Brief This Week: GATC Biotech; Eurofins Operon MWG; Progenika; Strand Life Sciences | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GATC Biotech this week said that it intends to analyze 100,000 human genomes within the next four year for pharmaceutical, diagnostic, and academic research customers. The sequencing services provider added that it will open a new business unit for human genome analysis at its headquarters in Germany. GATC said that it will use Illumina's HiSeq 2000 and Pacific Biosciences' RS systems to achieve its goal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.